Literature DB >> 7872181

Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus.

T M Winslow1, M A Ossipov, G P Fazio, J S Simonson, R F Redberg, N B Schiller.   

Abstract

The purpose of this study was to determine the prevalence and progression of pulmonary hypertension over a 5-year follow-up period in 28 patients with systemic lupus erythematosus (SLE) who were originally enrolled in an echocardiographic study of pulmonary hypertension in 1985 and 1986. Twenty healthy volunteers without cardiac or pulmonary disease participated as normal controls. Each patient and control underwent a complete Doppler echocardiographic study. Doppler echocardiographic recordings of tricuspid insufficiency, with saline contrast enhancement when necessary, were used to calculate pulmonary artery systolic pressure according to the modified Bernoulli equation. Doppler echocardiographic measurement of cardiac output was performed at rest for each subject, and pulmonary resistance was calculated by dividing the pulmonary artery systolic pressure by the cardiac output. These results were compared to results of the original studies to detect serial changes in pulmonary pressure and pulmonary resistance; results were also compared to the group of normal controls. The prevalence of pulmonary hypertension increased from 14% at the first study to 43% at follow-up. A significant increase in mean systolic pulmonary artery pressure was detected in the SLE patients during the follow-up period: 23.4 vs 27.5 mm Hg (p < 0.005). In addition, a significantly higher pulmonary artery pressure was detected in the SLE patients compared with the normal controls (p < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7872181     DOI: 10.1016/0002-8703(95)90278-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  22 in total

1.  Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center.

Authors:  M Funauchi; H Shimadzu; C Tamaki; T Yamagata; Y Nozaki; M Sugiyama; S Ikoma; K Kinoshita
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

2.  [Cardiovascular monitoring of patients with systemic lupus erythematosus].

Authors:  H Schotte; H Becker; W Domschke; M Gaubitz
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 3.  [Pulmonary arterial hypertension in collagenoses].

Authors:  M Claussen; G Riemekasten; M M Hoeper
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

4.  Improvement of severe pulmonary hypertension in a patient with SLE.

Authors:  M Karmochkine; B Wechsler; P Godeau; F Brenot; J L Jagot; G Simonneau
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

Review 5.  Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review.

Authors:  Heather Gladue; Nezam Altorok; Whitney Townsend; Vallerie McLaughlin; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2013-09-05       Impact factor: 5.532

Review 6.  Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis.

Authors:  Tian-Tian Lv; Peng Wang; Shi-Yang Guan; Hong-Miao Li; Xiao-Mei Li; Bin Wang; Hai-Feng Pan
Journal:  Ir J Med Sci       Date:  2017-12-18       Impact factor: 1.568

7.  Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.

Authors:  Shu-Zhen Xu; Xiang-Pei Li; Xiao-Mei Li; Zong-Wen Shuai; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2018-03-08       Impact factor: 2.980

8.  Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

Authors:  Ayse Cefle; Murat Inanc; Mehmet Sayarlioglu; Sevil Kamali; Ahmet Gul; Lale Ocal; Orhan Aral; Meral Konice
Journal:  Rheumatol Int       Date:  2009-12-11       Impact factor: 2.631

Review 9.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

10.  Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.

Authors:  Son-Mi Chung; Chang-Keun Lee; Eun Young Lee; Bin Yoo; Sang-Do Lee; Hee-Bom Moon
Journal:  Clin Rheumatol       Date:  2006-02-22       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.